| 标题 |
OA02. 03 Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced NSCLC: Longer follow-up of the MARIPOSA study
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Authors: Luis G. Paz-Ares, MD, PhD https://orcid.org/0000-0002-1947-3364 lpazaresr@seom.org, Oscar Juan-Vidal, MD https://orcid.org/0000-0002-7772-9030, Giannis S. Mountzios, MD, PhD https://orcid.org/0000-0002-7780-7836, Enriqueta Felip, MD, PhD https://orcid.org/0000-0002-7620-0098, Niels Reinmuth, MD, Filippo de Marinis, MD, PhD, Nicolas Girard, MD, PhD https://orcid.org/0000-0001-9909-2299, … Show All … , and Marina Chiara Garassino, MD https://orcid.org/0000-0002-3821-5598Authors Info & Affiliations |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Criminology34
山野下
spc68
Twonej
带头大哥
子车茗
wanci
eric888
专注的问寒
求助人员
lalala
香蕉诗蕊
pcr163
寻道图强
dew
Frank
yznfly
芳菲依旧
雨姐科研
Jared
herococa
浪子
半农
皖公网安备34019202002308
